Comprehensive Study Guide on Invertebrate and Vertebrate Endocrine Systems

Invertebrate Endocrine Systems

• Lower invertebrate taxa possess diffuse endocrine cells, whereas discrete endocrine glands occur primarily in mollusks and arthropods (reaching their highest complexity in arthropods).

• Invertebrate hormones are divided into three primary chemical classes:

  • Peptides and Neuropeptides: The most prevalent hormone class across invertebrate phyla.
  • Steroids: Lipid-soluble molecules structurally analogous to vertebrate steroids.
  • Terpenoids: Lipid-soluble hydrocarbons playing specialized roles in growth and development.

• Major physiological functions regulated by invertebrate hormones:

  • Regulation of body color changes
  • Growth and developmental transitions
  • Reproductive maturation and behaviors
  • Homeostasis, including basal metabolic regulation and osmoregulation

• Hormonal Control of Insect Metamorphosis:

  • Brain Hormone (BH) / Prothoracicotropic Hormone (PTTH): Synthesized by neurosecretory cells in the brain and stored/released by the corpus cardiacum. BH acts directly on the prothoracic gland to trigger the secretion of ecdysone.
  • Ecdysone: A steroid hormone (also termed molting hormone) secreted by the prothoracic gland. Ecdysone induces epidermal cell activity, cuticle secretion, and molting throughout larval, pupal, and adult transitions.
  • Juvenile Hormone (JH): A terpenoid hormone secreted by the corpus allatum. High concentrations of JH favor the retention of larval characteristics during a molt. A drop in JH concentration allows transition to the pupal stage, and the complete absence of JH during an ecdysone-stimulated molt results in metamorphosis into the adult stage.

General Glandular Physiology: Exocrine vs. Endocrine

• In vertebrates, glands function as effectors or reacting organs that produce and secrete chemical signals in response to physiological stimuli.

• Exocrine Glands:

  • Retain structural connections to epithelial surfaces via ducts or tubes.
  • Secretions (e.g., enzymes, sweat, mucus) pass through ducts directly onto external skin surfaces or internal lumen surfaces.

• Endocrine Glands:

  • Ductless glands derived from epithelial tissue that lose their surface connections during development.
  • Highly vascularized tissues that release secretions (hormones) directly into surrounding interstitial fluid, body fluids, or blood capillaries for systemic circulation.

• Structural Classification of Exocrine Glands:

• Simple Glands (Unbranched Duct):
  • Simple Tubular: Single straight tubular secretory unit connected to an unbranched duct.
  • Simple Branched Tubular: Multiple tubular secretory units emptying into a single unbranched duct.
  • Simple Coiled Tubular: Single coiled tubular secretory unit.
  • Simple Acinar: Single rounded, sac-like (acinous) secretory unit.
  • Simple Branched Acinar: Multiple sac-like secretory units connected to a single unbranched duct.
• Compound Glands (Branched Duct):
  • Compound Tubular: Repeatedly branching duct system with tubular secretory portions.
  • Compound Acinar: Repeatedly branching duct system with sac-like secretory portions.
  • Compound Tubuloacinar: Repeatedly branching duct system containing both tubular and acinar secretory units.

Chemical Classification of Hormones

• Lipid-Derived (Lipid-Soluble) Hormones:

  • Synthesized from cholesterol and share a multi-ringed steroid backbone structure.
  • Insoluble in aqueous blood plasma; require specific carrier or transport proteins for circulation.
  • Primary subclasses:
  • Gonadal Steroids: Estrogens and progesterone (females), androgens such as testosterone (males).
  • Adrenal Cortical Steroids: Mineralocorticoids (aldosterone), glucocorticoids (cortisol), and adrenal androgens.

• Amino Acid-Derived Hormones:

  • Small molecules synthesized from precursor amino acids, primarily tyrosine and tryptophan.
  • Nomenclature typically ends in "-ine" (e.g., epinephrine, norepinephrine, thyroxine, melatonin).

• Peptide and Protein Hormones:

  • Composed of linked amino acids ranging in size:
  • Short Polypeptide Chains: Antidiuretic hormone (ADH) and oxytocin (OT).
  • Small Proteins: Growth hormone (GH) and prolactin (PRL).
  • Large Glycoproteins: Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid-stimulating hormone (TSH).
  • Amino acid-derived and peptide hormones are water-soluble (hydrophilic) and circulate freely in plasma without carrier proteins.

Cellular Mechanisms of Hormone Action

• Nonsteroid / Water-Soluble Hormone Mechanism (Second Messenger System):

  1. The nonsteroid hormone acts as a first messenger and binds specifically to a cell-surface receptor protein embedded in the plasma membrane of the target cell.
  2. Receptor activation triggers an intracellular conformational change, activating membrane-bound enzymes (e.g., adenylyl cyclase via G-proteins).
  3. The activated enzyme converts Adenosine Triphosphate ($\text{ATP}$) into Cyclic Adenosine Monophosphate ($\text{cAMP}$), which acts as a second messenger.
  4. $\text{cAMP}$ activates intracellular protein kinases, initiating a signal cascade that alters cellular functions (e.g., accelerating enzymatic glycogen breakdown).

• Steroid / Lipid-Soluble Hormone Mechanism (Direct Gene Activation):

  1. Steroid hormones freely diffuse across the lipid bilayer of the target cell's plasma membrane.
  2. Inside the target cell, the hormone binds to specific intracellular receptor proteins located in the cytoplasm or nucleus.
  3. The resulting hormone-receptor complex enters the nucleus and binds directly to specific response elements on chromatin/$\text{DNA}$.
  4. Binding induces gene transcription, stimulating the synthesis of specific $\text{mRNA}$ molecules.
  5. $\text{mRNA}$ exits to the cytoplasm, where ribosomes translate it to synthesize new proteins that alter cell structure or activity.

• Thyroid Hormone Mechanism:

  • Thyroid hormones ($T_3$ and $T_4$) are transported across the plasma membrane.
  • They bind intracellular receptors inside the nucleus to activate gene transcription and protein synthesis.
  • Uniquely, thyroid hormones also bind directly to specific receptors on mitochondria, accelerating cellular respiration and $\text{ATP}$ production.

The Hypothalamus and Pituitary Axis (Hypophysis)

• Hypothalamus:
  • Located in the ventral forebrain, serving as the central integrator between the nervous system and the endocrine system.
  • Contains specialized neurosecretory cells that synthesize releasing hormones (RH) or releasing factors (RF) and inhibiting hormones (IH).
  • Hypothalamic regulatory hormones:
  • Corticotropin-releasing hormone (CRH)
  • Thyrotropin-releasing hormone (TRH)
  • Growth hormone-releasing hormone (GH-RH)
  • Growth hormone-inhibiting hormone (GH-IH) / Somatostatin
  • Prolactin-releasing factor (PRF)
  • Prolactin-inhibiting hormone (PIH) / Dopamine
  • Gonadotropin-releasing hormone (GnRH)

• Pituitary Gland (Hypophysis):
  • Pea-sized structure suspended from the base of the hypothalamus by a connecting stalk called the infundibulum.
  • Housed securely within the hypophyseal fossa of the sella turcica of the sphenoid bone at the skull base, situated posterior to the optic chiasm.
  • Anatomically and functionally divided into two distinct lobes:

- **Adenohypophysis (Anterior Pituitary Lobe):**
  - Composed of glandular epithelial tissue; divided into three regions: *pars tuberalis*, *pars intermedia*, and *pars distalis*.
  - Controlled by hypothalamic regulatory hormones delivered via the **hypophyseal portal system** (a specialized vascular network of primary capillaries in the median eminence, portal veins, and secondary capillaries in the anterior lobe).
- **Neurohypophysis (Posterior Pituitary Lobe):**
  - Composed of neural tissue (glial cells and nerve fibers); divided into the *infundibular stalk* and *pars nervosa*.
  - Does not synthesize hormones independently. Serves as a storage and release site for neurohormones synthesized in the hypothalamus.
  - Connected directly to the hypothalamus via the **hypothalamic-hypophyseal tract** (unmyelinated axons originating from neurosecretory neurons in the supraoptic and paraventricular nuclei).

Pituitary Hormones and Physiological Target Actions

• Adenohypophyseal (Anterior Pituitary) Hormones:

  • Thyroid-Stimulating Hormone (TSH) / Thyrotropin: Targets follicular cells of the thyroid gland to stimulate thyroid hormone synthesis and release.
  • Growth Hormone (GH) / Somatotropic Hormone (STH):
  • Targets the liver, skeletal muscle, bone, and adipose tissue.
  • Direct actions: Stimulates adipocytes to break down triglycerides and causes liver hepatocytes to perform glycogenolysis.
  • Indirect actions: Stimulates liver production of Insulin-like Growth Factors (IGFs) / Somatomedins, which increase amino acid uptake by target cells to promote protein synthesis, tissue growth, and bone elongation.
  • Prolactin (PRL) / Lactogenic Hormone: Targets mammary gland acinar cells to stimulate milk production and secretion.
  • Adrenocorticotropic Hormone (ACTH) / Adrenocorticotropin: Targets the adrenal cortex (specifically the zona fasciculata and zona reticularis) to stimulate glucocorticoid secretion.
  • Gonadotropins:
  • Follicle-Stimulating Hormone (FSH): Stimulates gamete production (ovarian follicle maturation in females; Sertoli cell activity/spermatogenesis in males).
  • Luteinizing Hormone (LH): Stimulates sex steroid production (triggers ovulation and corpus luteum formation in females; stimulates Leydig interstitial cells to produce testosterone in males).
  • Melanocyte-Stimulating Hormone (MSH): Secreted by the pars intermedia; targets cutaneous melanocytes to alter melanin distribution.

• Neurohypophyseal (Posterior Pituitary) Hormones:

  • Oxytocin (OT):
  • Synthesized in the paraventricular nucleus.
  • Stimulates smooth muscle contractions of the uterine myometrium during labor and contraction of myoepithelial cells in mammary alveoli for milk ejection ("let-down reflex").
  • Neural reflex pathway: Mechanical stimulation of nipple mechanoreceptors during suckling or auditory input (child's cry) signals higher brain centers and the hypothalamus to decrease PIH release while triggering oxytocin neuronal firing.
  • Antidiuretic Hormone (ADH) / Vasopressin:
  • Synthesized in the supraoptic nucleus.
  • Regulates body fluid osmolarity and blood volume.
  • Osmoreceptors in the hypothalamus detect increases in blood osmolarity above the normal set point of approximately $300\,\text{mOsm/L}$.
  • Triggered ADH release causes insertion of aquaporins into the distal convoluted tubules and collecting ducts of the kidneys, increasing water permeability and reabsorption back into the blood, reducing urine volume and restoring blood osmolarity.

Pituitary and Growth Disorders

• Growth Hormone Deviations:

  • Pituitary Dwarfism: Results from GH hyposecretion during childhood or congenital hypopituitarism (often caused by pituitary lesions or tumors). Characterized by short stature, delayed bone maturation, and delayed puberty, but proportional body growth.
  • Pituitary Gigantism: Results from GH hypersecretion during childhood prior to the epiphyseal plate closure in long bones. Characterized by excessive height, tall stature, elongated extremities, large hands and feet, and co-occurring metabolic strain.
  • Acromegaly: Results from GH hypersecretion in adulthood after epiphyseal plates have fused. Epiphyseal closure prevents height increase, resulting in progressive appositional growth and tissue thickening. Clinical features include:
  • Frequent headaches and visual field deficits (due to optic chiasm compression by pituitary adenomas)
  • Coarse facial features, frontal bossing, enlarged nose and lips, widely spaced teeth
  • Thickened skin creases, hyper-pigmentation, acanthosis nigricans
  • Enlarged hands, feet, and visceral organs

• Posterior Pituitary Disorders:

  • Diabetes Insipidus: Caused by neurogenic ADH hyposecretion or nephrogenic resistance (failure of renal tubules to respond to ADH). Characterized by severe polyuria (excretion of vast volumes of dilute urine) and compensatory polydipsia (intense constant thirst) due to an inability to reabsorb water.

The Thyroid Gland

• Anatomical Location: Situated in the anterior neck inferior to the larynx and thyroid cartilage, straddling and wrapped around the anterior and lateral walls of the trachea.

• Histological Organization: Composed of numerous spherical functional units called thyroid follicles lined by simple cuboidal follicular cells. Follicular cells enclose a central lumen filled with a viscous fluid named colloid (rich in thyroglobulin).

• Primary Thyroid Hormones:

  • Thyroxine ($T_4$): Contains four iodine atoms. Represents the major form secreted by the gland; acts as a circulating prohormone.
  • Triiodothyronine ($T_3$): Contains three iodine atoms. Formed intracellularly in target tissues via conversion from $T_4$ through deiodination ($T_4$ to $T_3$ conversion). $T_3$ is the metabolically active hormone form, possessing $200\times\text{ to }300\times$ greater biological activity/affinity for receptors than $T_4$.
  • Calcitonin (CT): Synthesized and secreted by parafollicular cells (C cells) located in the connective tissue spaces between thyroid follicles.

• Regulation of Thyroid Hormone Secretion:

  1. Cold exposure, stress, or low metabolic rates stimulate sensory inputs to the hypothalamus.
  2. Hypothalamic neurosecretory cells release Thyrotropin-Releasing Hormone (TRH) into the hypophyseal portal system.
  3. TRH binds anterior pituitary thyrotropes, inducing secretion of Thyroid-Stimulating Hormone (TSH) into systemic blood.
  4. TSH binds thyroid follicular cell receptors, stimulating colloid endocytosis, iodination, and secretion of $T_3$ and $T_4$ into circulation.
  5. Elevated levels of circulating $T_3$ and $T_4$ exert negative feedback control, inhibiting further release of TRH from the hypothalamus and TSH from the anterior pituitary.

• Systemic Functions of $T_3$ and $T_4$:

  • Increases basal metabolic rate (BMR) and cellular respiration rates across almost all body tissues.
  • Promotes growth, tissue development, and central nervous system maturation.
  • Potentiates sympathetic nervous system activity by increasing catecholamine receptor sensitivity and density.

Thyroid Pathophysiology

• Hypothyroidism (Deficiency of Thyroid Hormones):

  • Symptoms in Children: Short stature, stunted growth, rough/dry skin, cold intolerance, profound fatigue, easy bruising, delayed puberty.
  • Cretinism (Congenital Hypothyroidism): Caused by absent/hypoplastic thyroid gland development or severe maternal iodine deficiency during pregnancy. Leads to irreversible intellectual disability, stunted physical growth, and organ failure.
  • Hashimoto's Disease: An autoimmune condition where autoantibodies target and destroy thyroid follicular tissue. It is a leading cause of primary hypothyroidism. Clinical signs include brain fog, fatigue, goiter development, constipation, menstrual irregularities, dry skin, brittle nails, and joint/muscle pain.

• Hyperthyroidism (Excess of Thyroid Hormones):

  • Graves' Disease: An autoimmune disorder caused by thyroid-stimulating immunoglobulins (TSI) that bind to and chronically activate TSH receptors on follicular cells, producing excessive $T_3$ and $T_4$ independent of pituitary control.
  • Clinical Manifestations: Weight loss despite increased appetite, heat intolerance, hyperhidrosis, anxiety, tremor, fatigue, muscle weakness, erectile dysfunction, infertility, diffuse goiter (toxic multinodular goitre), exophthalmos (bulging eyes due to retro-orbital tissue inflammation), and pretibial myxedema.

The Parathyroid Glands and Calcium Homeostasis

• Anatomical Structure: Four tiny, yellowish-brown oval masses located on the posterior surface of the lobes of the thyroid gland. Each individual gland weighs approximately $30\,\text{mg}$ and measures $3\text{--}4\,\text{mm}$ in diameter.
• Parathyroid Hormone (PTH) / Parathormone: Secreted by chief cells in response to hypocalcemia (falling blood calcium levels below the homeostatic set point of approximately $10\,\text{mg/100\,mL}$ or $2.5\,\text{mmol/L}$).

• Antagonistic Endocrine Control of Blood Calcium ($\text{Ca}^{2+}$):

  • When Blood $\text{Ca}^{2+}$ Level Drops Below Normal (PTH Response):
  1. Parathyroid glands detect low blood $\text{Ca}^{2+}$ and release PTH into the blood.
  2. PTH stimulates osteoclast activity in bone matrix, releasing $\text{Ca}^{2+}$ into blood circulation.
  3. PTH acts on kidney tubule cells to increase renal reabsorption of $\text{Ca}^{2+}$ from tubular fluid.
  4. PTH activates the enzymatic conversion of Vitamin D into active Calcitriol (Active Vitamin D) in the kidneys.
  5. Calcitriol acts on intestinal mucosal epithelial cells to increase $\text{Ca}^{2+}$ absorption from ingested food, elevating blood $\text{Ca}^{2+}$ back to homeostatic baseline.
  • **When Blood $Libraries\text{Ca}^{2+} Level Rises Above Normal (Calcitonin Response):**\n 1. Thyroid C-cells detect elevated blood \text{Ca}^{2+} and release **Calcitonin (CT)**.\n 2. Calcitonin inhibits osteoclasts and stimulates osteoblast activity, promoting \text{Ca}^{2+} deposition into bone tissue.\n 3. Calcitonin reduces renal tubular \text{Ca}^{2+}$reabsorption, increasing calcium excretion in urine to lower blood$\text{Ca}^{2+} levels.\n\n\n# The Adrenal Glands (Suprarenal Glands)\n\n\n\n- **Anatomical Location:** Paired organs positioned retroperitoneally superior to the apex of each kidney.\n- **Morphology:** Asymmetrical shapes; the **right adrenal gland** is pyramidal/triangular, whereas the **left adrenal gland** is crescent/semilunar in shape.\n- **Histological Division:** Anatomically divided into two distinct functional layers, each derived from different embryonic origins and secreting separate hormone profiles:\n\n\n\n- **Adrenal Medulla (Inner Layer):**\n - Derived from neuroectoderm; functionally acts as a modified sympathetic ganglion populated by chromaffin cells.\n - Directly innervated by preganglionic sympathetic nerve fibers coming from the spinal cord.\n - Secretes **Catecholamines** in response to acute stress:\n - **Epinephrine (Adrenaline)**\n - **Norepinephrine (Noradrenaline)**\n - **Short-Term Stress Response ("Fight-or-Flight"):**\n - Triggers hepatic glycogenolysis (glycogen broken down to glucose, raising blood glucose concentration).\n - Increases heart rate, cardiac output, and arterial blood pressure.\n - Increases breathing rate and induces bronchiole dilation in the lungs.\n - Elevates basal metabolic rate.\n - Alters blood flow distribution, directing perfusion toward skeletal muscle and brain while dampening digestive and renal activity.\n\n- **Adrenal Cortex (Outer Layer):**\n - Derived from mesoderm; glandular tissue divided into three concentric zones under the direct control of pituitary **ACTH**.\n - Secretes **Corticosteroids**:\n - **Mineralocorticoids (e.g., Aldosterone):** Secreted by the zona glomerulosa. Promotes renal tubular retention of sodium ions (\text{Na}^+$) and water coupled with potassium ($\text{K}^+) excretion, expanding blood volume and blood pressure.\n - **Glucocorticoids (e.g., Cortisol):** Secreted by the zona fasciculata. Stimulates gluconeogenesis (protein and fat breakdown converted to glucose), increases plasma blood glucose, and exerts potent anti-inflammatory and immunosuppressive effects.\n - **Adrenal Steroids / Sex Hormones (Androgens & Estrogens):** Secreted by the zona reticularis; contributes to secondary sexual characteristics.\n - **Long-Term Stress Response:** Mediated via ACTH-stimulated corticosteroid release, maintaining elevated blood glucose via protein/fat catabolism and expanding extracellular fluid volume through water and \text{Na}^+ retention.\n\n\n# Pathophysiology of the Adrenal Cortex\n\n- **Cushing's Syndrome (Adrenocortical Hypersecretion / Hypercortisolism):**\n - Caused by excessive glucocorticoid/cortisol secretion (often due to ACTH-secreting pituitary adenomas or adrenal tumors).\n - Clinical Signs:\n - Central obesity with distinct fat deposition on the face (**"Moon Face"**) and dorsocervical spine (**"Buffalo Hump"**).\n - Hyperglycemia (steroid-induced diabetes).\n - Fluid and \text{Na}^+ retention causing systemic edema and hypertension.\n - Protein wasting leading to muscle atrophy, thin extremities, fragile thin skin, purple abdominal striae, and easy bruising/petechiae.\n - Osteoporosis and increased fracture risk.\n - Gastrointestinal acid distress, CNS irritability, mood changes, and increased susceptibility to infection.\n - Endocrine disturbances: Amenorrhea and hirsutism in females; gynecomastia in males.\n\n- **Addison's Disease (Adrenocortical Insufficiency / Hypcortisolism):**\n - Caused by autoimmune destruction or degeneration of all layers of the adrenal cortex, resulting in inadequate glucocorticoid and mineralocorticoid secretion.\n - Clinical Signs:\n - Hyperpigmentation of skin and mucous membranes (**Bronze Pigmentation**) due to elevated compensatory ACTH/MSH secretion.\n - Hypoglycemia, muscle weakness, profound fatigue, weight loss, and gastrointestinal disturbances.\n - Loss of aldosterone leads to hyponatremia (low serum \text{Na}^+$), hyperkalemia (high serum$\text{K}^+), severe dehydration, and postural hypotension.\n - **Adrenal Crisis (Addisonian Crisis):** Acute life-threatening emergency characterized by profound fatigue, severe dehydration, vascular collapse (precipitous drop in blood pressure), and acute renal shutdown.\n\n\n# The Enteric Endocrine System\n\n- Specialized enteroendocrine cells dispersed throughout the mucosa of the gastrointestinal tract produce peptide hormones controlling digestion:\n\n- **Stomach:**\n - **G Cells (located in gastric glands/pits):** Synthesize and release **Gastrin** in response to stomach distension and protein entry. Gastrin targets parietal cells to stimulate gastric hydrochloric acid (\text{HCl}) secretion and chief cells to stimulate pepsinogen release.\n\n- **Small Intestine (Duodenal Epithelium):**\n - **Secretin:** Released by S cells in response to acidic chyme entering the duodenum. Targets pancreatic duct cells and the liver to stimulate the secretion of bicarbonate-rich (\text{HCO}_3^-) fluids that neutralize stomach acid; inhibits gastric motility and gastric acid secretion.\n - **Cholecystokinin (CCK):** Released by I cells in response to dietary fats and proteins in the duodenum. Stimulates pancreatic acinar cells to secrete digestive enzymes, induces gallbladder smooth muscle contractions to release bile into the duodenum, and relaxes the sphincter of Oddi.\n\n\n# The Pancreas and Blood Glucose Regulation\n\n- **Anatomical Structure:** A elongated, nodular heterocrine (mixed) gland located retroperitoneally along the inner C-shaped curve of the duodenum.\n- **Dual Structural Divisions:**\n - **Exocrine Pancreas (99% of tissue mass):** Composed of **Pancreatic Acini (Acinar Cells)** that produce digestive zymogens and enzymes secreted via the pancreatic duct into the duodenum.\n - **Endocrine Pancreas (Islets of Langerhans / Pancreatic Islets):** Approximately 1 to 2 million microscopic cell clusters scattered among acini, richly surrounded by blood capillaries into which hormones are secreted.\n\n\n\n- **Cellular Composition of the Islets of Langerhans:**\n - **Alpha (\alpha) Cells:** Synthesize and secrete **Glucagon**.\n - **Beta (\beta) Cells:** Synthesize and secrete **Insulin**.\n - **Delta (\delta) Cells:** Synthesize and secrete **Somatostatin (SST)**.\n - **F Cells (PP Cells):** Synthesize and secrete **Pancreatic Polypeptide (PP)**.\n\n- **Pancreatic Hormones and Actions:**\n - **Insulin:** Secreted in response to **hyperglycemia** (elevated blood glucose above the normal set point of \sim 90\,\text{mg/100\,mL}$or$5\,\text{mmol/L}).\n - Lowers blood glucose by enhancing facilitated diffusion of glucose into skeletal muscle cells and adipocytes.\n - Accelerates **glycogenesis** (conversion of glucose into glycogen) in the liver and skeletal muscle.\n - Inhibits glycogenolysis and gluconeogenesis.\n - **Glucagon:** Secreted in response to **hypoglycemia** (falling blood glucose levels below \sim 90\,\text{mg/100\,mL}).\n - Targets hepatocytes in the liver to induce **glycogenolysis** (breakdown of stored glycogen into glucose) and **gluconeogenesis** (conversion of amino acids/glycerol into glucose).\n - Glucose is released into systemic blood, restoring normoglycemia.\n\n\n\n - **Somatostatin (SST) / Growth Hormone-Inhibiting Hormone (GHIH):** Acts locally as a paracrine factor to inhibit the secretion of both insulin and glucagon; slows nutrient absorption rates in the GI tract. (Also secreted by neurosecretory neurons in the hypothalamus).\n - **Pancreatic Polypeptide (PP):** Self-regulates pancreatic exocrine and endocrine secretion rates; inhibits gallbladder contraction and biliary motility.\n\n\n# Diabetes Mellitus\n\n- Metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Cells are unable to absorb glucose, leading to cellular starvation amid extracellular nutrient excess.\n\n- **Type 1 Diabetes Mellitus (IDDM - Insulin-Dependent Diabetes Mellitus):**\n - Caused by an autoimmune destruction of pancreatic \beta cells, leading to absolute insulin deficiency.\n - Most commonly diagnosed in children and juveniles, but can manifest at any age.\n - Requires lifelong exogenous insulin therapy for survival.\n\n- **Type 2 Diabetes Mellitus (NIDDM - Non-Insulin-Dependent Diabetes Mellitus):**\n - Characterized by **insulin resistance** (target cell tissues display diminished responsiveness to circulating insulin) paired with progressive secretory defects in \beta$$ cells.
  • Strong association with obesity, physical inactivity, and metabolic syndrome.
  • Can be managed or controlled through weight reduction, nutritional interventions, exercise, and oral hypoglycemic agents.

• Gestational Diabetes Mellitus (GDM):

  • Hyperglycemia triggered by placental counter-regulatory hormones during pregnancy.
  • Requires strict glycemic monitoring and control to prevent fetal macrosomia and developmental complications.

The Male Reproductive Endocrine System (Testes)

• Anatomical Structure: Paired male gonads contained outside the abdominopelvic cavity within the scrotum.
• Endocrine Elements:
  • Interstitial Cells of Leydig: Situated in the connective tissue spaces between seminiferous tubules. Synthesize and secrete male androgens, primarily Testosterone, under direct LH stimulation.
  • Sertoli Cells (Nurse Cells): Located inside seminiferous tubules. Stimulated by FSH and local testosterone to support and nourish developing sperm cells during spermatogenesis.

• Hypothalamic-Pituitary-Gonadal Axis in Males:

  1. Hypothalamus secretes GnRH into the hypophyseal portal system.
  2. Anterior pituitary gonadotropes release FSH and LH into the blood.
  3. LH targets Leydig cells, stimulating Testosterone (T) synthesis.
  4. FSH and Testosterone target Sertoli cells, inducing spermatogenesis.
  5. Sertoli cells release Inhibin, which selectively inhibits anterior pituitary FSH release via negative feedback.
  6. Circulating testosterone exerts negative feedback control on both the hypothalamus (inhibiting GnRH) and the anterior pituitary (inhibiting LH).

• Systemic Physiological Effects of Testosterone:

  • Skin: Stimulates facial/body hair distribution and collagen synthesis.
  • Muscles: Promotes muscle protein anabolism, increasing muscle mass, strength, and endurance.
  • Bones: Maintains bone mass density and structural bone growth.
  • Brain: Maintains libido, regulates mood, confidence, and cognitive memory functions.
  • Bone Marrow: Stimulates erythropoietin action, increasing red blood cell production.
  • Sex Organs: Drives male genital development during embryogenesis, prostate gland growth, sperm production, and erectile function.

The Female Reproductive Endocrine System (Ovaries)

• Anatomical Structure: Paired oval glands located in the pelvic cavity on either side of the uterus, positioned adjacent to the fimbriae of the fallopian tubes.
• Endocrine Structures and Hormones:
  • Ovarian Follicle: Surrounds the developing oocyte. Granulosa and theca cells produce Estrogens (primarily Estradiol) in response to pituitary FSH and LH.
  • Corpus Luteum: Temporary endocrine structure formed from the ruptured follicle post-ovulation under LH influence. Secretes high levels of Progesterone, as well as estrogens and inhibin.

• Systemic Physiological Effects of Estrogen:

  • Brain: Controls body temperature regulation in the hypothalamus, supports memory function, and adjusts libido.
  • Liver: Regulates hepatic cholesterol synthesis, lowering LDL accumulation and protecting the vascular heart against atherosclerosis.
  • Bones: Maintains bone mineral density and strength by inhibiting osteoclasts.
  • Skin: Exerts anti-aging effects, preserving elasticity and structural integrity.
  • Breasts: Induces ductal growth and breast tissue development.
  • Ovaries & Uterus: Drives follicular maturation and stimulates endometrial proliferation during the monthly uterine cycle.

• Systemic Physiological Effects of Progesterone:

  • Uterus: Prepares the vascularized endometrial lining for blastocyst implantation and maintains pregnancy (produced initially by the corpus luteum, later by the placenta).
  • Nervous System: Regulates mood, aids cognition, supports nervous tissue growth, displays anti-epileptic neuroprotective properties, and exerts a sedative effect promoting sleep.

• Hormonal Regulation of the Female Reproductive Cycle:

  • Follicular Phase: Hypothalamic GnRH drives FSH/LH release. Primary follicles mature into Graafian follicles, secreting rising levels of estrogen that induce the proliferative phase in the endometrium.
  • Ovulation: High threshold levels of estrogen exert positive feedback on the anterior pituitary, triggering a massive surge of LH (and FSH) around Day 14, causing follicle rupture and oocyte release.
  • Luteal Phase: Ruptured follicle collapses to form the corpus luteum, secreting large amounts of progesterone and estrogen. Progesterone converts the endometrium into a secretory phase. High progesterone and inhibin exert negative feedback on GnRH, LH, and FSH.
  • Menses: If fertilization does not occur, the corpus luteum degenerates into a fibrotic corpus albicans. Steroid levels drop sharply, causing endometrial vascular constriction and sloughing (menstruation/menses).

The Pineal Gland

• Anatomical Location: Small pinecone-shaped structure attached to the roof of the third ventricle in the epithalamus of the brain.
• Hormone Produced: Melatonin (an amino acid-derived hormone synthesized from tryptophan).
• Physiological Role and Regulation:
  • Regulates circadian rhythms, sleep-wake cycles, and seasonal reproductive photoperiods.
  • Photic Regulation: Retinal ganglion cells detect environmental light levels and signal the suprachiasmatic nucleus (SCN) of the hypothalamus. Environmental darkness removes retinal inhibition, activating pineal melatonin synthesis and release into blood and cerebrospinal fluid. Ambient light exposure rapidly suppresses melatonin synthesis.